Disclosed are native liquid chromatography-mass spectrometry systems and methods of use. A native liquid chromatography-mass spectrometry system can include a liquid chromatography system capable of separating a sample; and an electrospray ionization mass spectrometry (ESI-MS) system in fluid communication with the liquid chromatography system, wherein the ESI-MS system comprises a multi-nozzle electrospray ionization emitter and a system for modifying a desolvation gas and a mass spectrometer, wherein the mass spectrometer is configured to receive ions and characterize mass to charge ratio of ions.

The present invention relates to a method for the detection and quantification of fosfomycin and impurities and/or degradation products thereof in samples of fosfomycin or a pharmaceutically acceptable salt thereof or in pharmaceutical compositions comprising fosfomycin or a pharmaceutically acceptable salt thereof. The present invention further relates to a process for manufacturing fosfomycin, or a pharmaceutically acceptable salt thereof having a specified purity degree, as well as to the fosfomycin or a pharmaceutically acceptable salt thereof as obtained. The present invention further relates to a process for manufacturing a pharmaceutical composition comprising fosfomycin or a pharmaceutically acceptable salt thereof and at least one pharmaceutically acceptable excipient having a specified purity degree, as well as to the pharmaceutical composition as obtained.

The present invention relates to a method for the detection and quantification of fosfomycin and impurities and/or degradation products thereof in samples of fosfomycin or a pharmaceutically acceptable salt thereof or in pharmaceutical compositions comprising fosfomycin or a pharmaceutically acceptable salt thereof. The present invention further relates to a process for manufacturing fosfomycin, or a pharmaceutically acceptable salt thereof having a specified purity degree, as well as to the fosfomycin or a pharmaceutically acceptable salt thereof as obtained. The present invention further relates to a process for manufacturing a pharmaceutical composition comprising fosfomycin or a pharmaceutically acceptable salt thereof and at least one pharmaceutically acceptable excipient having a specified purity degree, as well as to the pharmaceutical composition as obtained.

The present invention includes a first flow path through which a sample gas flows, a first analyzer that is provided in the first flow path to measure total hydrocarbon concentration in the sample gas, a second flow path through which the sample gas flows, a non-methane non-ethane cutter that is provided in the second flow path to remove the hydrocarbon components other than the methane and the ethane in the sample gas, a second analyzer that is provided downstream of the non-methane non-ethane cutter in the second flow path to measure the total methane ethane concentration of the methane and the ethane in the sample gas, and a calculation part that calculates the concentration of the hydrocarbon components other than the methane and the ethane in the sample gas with use of the total hydrocarbon concentration by the first analyzer and the total methane ethane concentration by the second analyzer.

Systems and methods that facilitate the automatic (or substantially automatic) preparation of a sample of a product containing molecules for analysis and automatic (or substantially automatic) performance of an assay of that sample. Thus, the preparation and analysis can be performed substantially in-real time, or, in other words, much more quickly than presently allowed by conventional systems and methods.

Systems and methods that facilitate the automatic (or substantially automatic) preparation of a sample of a product containing molecules for analysis and automatic (or substantially automatic) performance of an assay of that sample. Thus, the preparation and analysis can be performed substantially in-real time, or, in other words, much more quickly than presently allowed by conventional systems and methods.

An odor evaluation device, including: a gas chromatograph including a separation column configured to temporally separate a plurality of components contained in an odoriferous analysis-target gas; a timing detector configured to detect, for each of the plurality of components, a timing at which the component exits from the separation column; a gas collector configured to collect, into a sample bag, a gas containing all or some of the components exiting from the separation column when the analysis-target gas is passed through the separation column; a timing setter configured to allow a setting of a timing at which a component contained in the gas to be collected into the sample bag exits from the separation column; and a gas introducer configured to introduce a dilution gas into a passage connecting the separation column and the sample bag.

A gas separation system includes a separation column for separating components contained in sample gas, a sample gas supplier fluidly connected to an inlet of the separation column for supplying sample gas to the separation column, a detector fluidly connected to an outlet of the separation column, a collection tube filled with an adsorbent having a property of adsorbing a target component in the sample gas under a condition of a first temperature or less and desorbing the adsorbed target component under a condition of a second temperature or more higher than the first temperature, a temperature adjuster for adjusting a temperature of the collection tube, a collection container for collecting the target component, and a switching mechanism for switching between a state in which the collection tube is connected to an outlet of the detector and a state in which the collection tube is connected to the collection container.

A system for separation of components of a natural gas product uses a first separation column to receive the natural gas product and to provide first stage components including a first component gas, uses a gas converter to provide second stage components that includes third component gas from at least a second component gas of such first stage components, and uses a second separation column to provide third stage components that includes the first component gas, the third component gas, and one or more additional carbon-based components provided in or over a period of time associated with the separation of the components of the natural gas product.

A system for determining isotopic composition of a gaseous sample. The system includes at least one gas chromatograph for separating the gaseous sample into gaseous components. Furthermore, the system includes a combustion furnace operatively coupled with the at least one gas chromatograph for oxidizing the gaseous components. Moreover, the system includes a water separator operatively coupled with the combustion furnace. Furthermore, the system includes an isotope-ratio mass spectrometer operatively coupled with the water separator. Moreover, the isotope-ratio mass spectrometer comprises an ion source for generating ion beams associated with each of the oxidized gaseous components and a mass analyser for receiving the generated ion beams from the ion source, wherein the mass analyser is operable to determine isotopic concentrations associated with each of the ion beams. Furthermore, the isotope-ratio mass spectrometer is operable to use the determined isotopic concentrations to determine the isotopic composition of the gaseous sample.